Efficacy of oral treprostinil as an add-on therapy for PAH

被引：0
|
作者：
Kiely, D. [1 ]
Gruenig, E. [2 ]
Balasubramanian, V [3 ]
Barbera, J. [4 ]
Vizza, C. D. [5 ]
Elwing, J. [6 ]
Sood, N. [7 ]
Rao, Y. [8 ]
Holdstock, L. [8 ]
Seaman, S. [8 ]
Broderick, M. [8 ]
White, R. J. [9 ]
机构：
[1] Univ Sheffield, Sheffield, S Yorkshire, England
[2] Univ Hosp Heidelberg, Thoraxclin, Heidelberg, Germany
[3] Univ Calif San Francisco, Fresno, CA USA
[4] Hosp Clin Barcelona, Barcelona, Spain
[5] Sapienza Univ Rome, Rome, Italy
[6] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA
[7] Univ Calif Davis, Davis Hlth, Davis, CA 95616 USA
[8] United Therapeut Corp, Res Triangle Pk, NC USA
[9] Univ Rochester, Med Ctr, Rochester, NY 14627 USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
Pulmonary hypertension; Physical activity; Adults;
D O I：
10.1183/13993003.congress-2022.154
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
154
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Add-on treprostinil therapy and PAH
    Osório J.
    Nature Reviews Cardiology, 2010, 7 (7) : 359 - 359
  • [2] Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension
    Ivy, D. Dunbar
    Feinstein, Jeffrey A.
    Yung, Delphine
    Mullen, Mary P.
    Kirkpatrick, Edward C.
    Hirsch, Russel
    Austin, Eric D.
    Fineman, Jeffrey
    Truong, Uyen
    Solum, Derek
    Deng, C. Q.
    Hopper, Rachel K.
    PULMONARY CIRCULATION, 2019, 9 (03)
  • [3] Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension
    Channick, RN
    Olschewski, H
    Seeger, W
    Staub, T
    Rubin, LJ
    CIRCULATION, 2005, 112 (17) : U566 - U566
  • [4] Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension
    Channick, Richard N.
    Olschewski, Horst
    Seeger, Werner
    Staub, Ted
    Voswinckel, Robert
    Rubin, Lewis J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (07) : 1433 - 1437
  • [5] Transition to Oral Treprostinil from Parenteral or Inhaled Treprostinil or as Add-On Therapy in Pediatric Subjects with Pulmonary Arterial Hypertension
    Ivy, D.
    Feinstein, J.
    Yung, D.
    Mullen, M.
    Kirkpatrick, E.
    Hirsch, R.
    Austin, E. D.
    Fineman, J.
    Doran, A.
    Solum, D.
    Deng, C.
    Hopper, R. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [6] Intravenous treprostinil as an add-on therapy in patients with pulmonary arterial hypertension
    Olsson, Karen M.
    Richter, Manuel J.
    Kamp, Jan C.
    Gall, Henning
    Heine, Alexander
    Ghofrani, Hossein-Ardeshir
    Fuge, Jan
    Ewert, Ralf
    Hoeper, Marius M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (07): : 748 - 756
  • [7] Add-On Therapy with Subcutaneous Treprostinil for Refractory Pediatric Pulmonary Hypertension
    Levy, Marilyne
    Celermajer, David S.
    Bourges-Petit, Elisabeth
    Del Cerro, Maria-Jesus
    Bajolle, Fanny
    Bonnet, Damien
    JOURNAL OF PEDIATRICS, 2011, 158 (04): : 584 - 588
  • [8] Hypertension: Treprostinil therapy for PAH
    Lim G.B.
    Nature Reviews Cardiology, 2013, 10 (3) : 119 - 119
  • [9] Efficacy and dose-response relationship of oral treprostinil in PAH patients on monotherapy or dual background therapy
    Barbera, J. A.
    Kiely, D.
    Gruenig, E.
    Balasubramanian, V.
    Vizza, C. D.
    Elwing, J.
    Sood, N.
    Rao, Y.
    Holdstock, L.
    Seaman, S.
    Broderick, M.
    White, R. J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1920 - 1920
  • [10] Safety and efficacy of doxazosin as an add-on antihypertensive therapy
    Roccaforte, R.
    Fragasso, G.
    Spaladore, R.
    Calori, G.
    Arioli, F.
    Margonato, A.
    JOURNAL OF HYPERTENSION, 2006, 24 : S141 - S141
12345